#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	1700	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2623	191.4	0	.	n	.	0	C451T	SNP	451	451	C	1004	1004	T	237	T,C	158,52	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	1700	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2623	191.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1737	1737	C	232	C	213	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	1700	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2623	191.4	0	HET	.	.	.	C328G,T	.	328	328	C	881	881	C	218	C,G,T	161,42,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	1700	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2623	191.4	0	HET	.	.	.	C1450T,G	.	1450	1450	C	2003	2003	C	235	C,T,G	162,58,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	1700	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2623	191.4	0	HET	.	.	.	C207T	.	207	207	C	760	760	C	218	C,T	152,43	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2558	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4032	189.9	0	.	n	.	0	T695C	SNP	695	695	T	1254	1254	C	186	C,A	164,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2558	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4032	189.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2530	2530	C	285	C	261	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2558	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4032	189.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3156	3156	T	218	T	197	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2558	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4032	189.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2604	2604	A	304	A,C	270,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	278	folP	855	855	100.0	folP.l15.c4.ctg.1	2004	41.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1251	1253	AGC	53;53;53	A;G;C	49;51;51	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	634	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3887	48.8	1	SNP	p	S91F	1	.	.	271	273	TTC	895	897	TTC	50;50;50	T;T;C	44;44;43	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	634	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3887	48.8	1	SNP	p	D95G	1	.	.	283	285	GGC	907	909	GGC	49;49;49	G;G;C	43;43;42	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	634	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3887	48.8	1	SNP	p	G95N	0	.	.	283	285	GGC	907	909	GGC	49;49;49	G;G;C	43;43;42	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	266	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1774	45.0	1	SNP	p	G45D	0	.	.	133	135	GGC	695	697	GGC	65;65;64	G;G;C	60;60;59	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	142	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1319	31.9	0	.	n	.	0	A197.	DEL	197	197	A	756	756	A	52	A	52	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	560	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3279	51.1	1	SNP	p	D86N	0	.	.	256	258	GAC	712	714	GAC	57;57;57	G;A;C	50;49;50	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	560	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3279	51.1	1	SNP	p	S87R	1	.	.	259	261	CGT	715	717	CGT	58;60;60	C;G;T	51;53;48	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	560	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3279	51.1	1	SNP	p	R87I	0	.	.	259	261	CGT	715	717	CGT	58;60;60	C;G;T	51;53;48	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	560	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3279	51.1	1	SNP	p	R87W	0	.	.	259	261	CGT	715	717	CGT	58;60;60	C;G;T	51;53;48	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	560	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3279	51.1	1	SNP	p	S88P	0	.	.	262	264	TCC	718	720	TCC	60;60;60	T;C;C	51;52;51	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	486	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3303	44.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1938	1940	GGC	48;49;49	G;G;C	44;43;44	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2792	47.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1502	1504	GCC	57;57;57	G;C;C	48;48;48	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2792	47.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1505	1507	ATG	57;57;57	A;T;G	51;49;50	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2792	47.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1517	1519	ACC	58;58;58	A;C;C	52;51;52	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2792	47.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1517	1519	ACC	58;58;58	A;C;C	52;51;52	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2792	47.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2018	2020	ACC	39;40;40	A;C;C	38;35;39	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2792	47.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2072	2074	GCG	41;41;41	G;C;G	39;39;39	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2792	47.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2072	2074	GCG	41;41;41	G;C;G	39;39;39	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2792	47.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2195	2197	GGT	48;48;48	G;G;T	41;41;45	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2792	47.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2204	2206	AGC	48;48;48	A;G;C	42;42;42	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2792	47.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2222	2224	CCG	46;46;45	C;C;G	40;43;37	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	610	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3529	51.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1864	1866	CCG	55;55;55	C,A;C;G	47,1;51;47	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	360	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2396	44.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	910	910	C	46	C	42	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	287	91.07	porB1a.l6.c17.ctg.1	871	12.2	0	.	p	.	0	H217N	NONSYN	649	651	CAT	313	315	AAT	8;8;8	A;A;T	7;6;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	287	91.07	porB1a.l6.c17.ctg.1	871	12.2	0	.	p	.	0	D218N	NONSYN	652	654	GAT	316	318	AAT	8;8;8	A;A;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	287	91.07	porB1a.l6.c17.ctg.1	871	12.2	0	.	p	.	0	V226A	NONSYN	676	678	GTA	340	342	GCA	7;7;7	G;C;A	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	287	91.07	porB1a.l6.c17.ctg.1	871	12.2	0	.	p	.	0	.	MULTIPLE	700	702	ACT	363	365	GTA	7;7;7	G;T;A	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	287	91.07	porB1a.l6.c17.ctg.1	871	12.2	0	.	p	.	0	N237fs	FSHIFT	709	709	A	372	372	A	7	A	6	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	322	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	2069	46.2	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1167	1169	AGA	68;68;68	A;G;A	60;59;58	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	322	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	2069	46.2	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1188	1190	GGT	65;65;63	G,T;G;T	59,1;59;59	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	322	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	2069	46.2	1	SNP	p	G120K	1	.	.	358	360	AAG	897	899	AAG	59;59;59	A;A;G	55;55;55	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	322	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	2069	46.2	1	SNP	p	A121N	1	.	.	361	363	AAC	900	902	AAC	59;59;58	A,T;A;C	54,1;55;56	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	322	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	2069	46.2	1	SNP	p	N121D	0	.	.	361	363	AAC	900	902	AAC	59;59;58	A,T;A;C	54,1;55;56	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1038	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5393	57.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	150	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1552	29.0	1	SNP	p	V57M	1	.	.	169	171	ATG	817	819	ATG	63;63;62	A;T;G	55;55;57	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
